High dose chemotherapy for breast cancer queried

BMJ 1998; 317 doi: (Published 22 August 1998) Cite this as: BMJ 1998;317:490

This article has a correction. Please see:

  1. Deborah Josefson
  1. San Francisco

    No evidence exists to support high dose chemotherapy rather than standard regimens for treating breast cancer, according to a report in the Lancet (1998;352:515-21).

    Despite recent advances in detection, breast cancer recurrence is commonSome reports have suggested that high dose chemotherapy might be superior to standard treatments, and several small scale reports have also suggested an increase in disease free survival with high dose regimens compared with conventional treatments. Some centres routinely offer …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription